Biological treatment in rheumatic diseases: results from a longitudinal surveillance : adverse events

The objective of this study was to assess the long-term safety and tolerability of biologicals in a clinical setting. Data on adverse events (AEs) have been collected over a 5-year period by means of detailed reports sent in to the National Register of Biological Treatment in Finland (ROB-FIN) and v...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology international 2006-08, Vol.26 (10), p.916-922
Hauptverfasser:	KONTTINEN, L, HONKANEN, V, NORDSTROM, D. C, UOTILA, T, PÖLLÄNEN, J, WAAHTERA, M, ROMU, M, PUOLAKKA, K, VASALA, M, KARJALAINEN, A, LUUKKAINEN, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antirheumatic Agents - adverse effects Antirheumatic Agents - immunology Antirheumatic Agents - therapeutic use Biological and medical sciences Cohort Studies Diseases of the osteoarticular system Drug Therapy, Combination Female Finland - epidemiology Humans Longitudinal Studies Male Medical sciences Medical treatment Middle Aged Miscellaneous. Osteoarticular involvement in other diseases Pharmaceutical industry Population Surveillance Registries Retrospective Studies Rheumatic diseases Rheumatic Diseases - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!